130 related articles for article (PubMed ID: 7782162)
21. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G.
Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF
J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748
[TBL] [Abstract][Full Text] [Related]
22. A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity.
Alexopoulos K; Matsoukas J; Tselios T; Roumelioti P; Mavromoustakos T; Holada K
Amino Acids; 1998; 15(3):211-20. PubMed ID: 9871500
[TBL] [Abstract][Full Text] [Related]
23. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
24. Solution structure of a platelet receptor peptide bound to bovine alpha-thrombin.
Ni F; Ripoll DR; Martin PD; Edwards BF
Biochemistry; 1992 Nov; 31(46):11551-7. PubMed ID: 1332764
[TBL] [Abstract][Full Text] [Related]
25. Development of a potent thrombin receptor ligand.
Feng DM; Veber DF; Connolly TM; Condra C; Tang MJ; Nutt RF
J Med Chem; 1995 Sep; 38(20):4125-30. PubMed ID: 7562949
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of thrombin receptor-derived nonpeptide mimetics utilizing a piperazine scaffold.
Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Smith J; Mavromoustakos T; Saifeddine M; Moore G; Hollenberg M; Matsoukas J
Bioorg Med Chem; 1999 Jun; 7(6):1033-41. PubMed ID: 10428371
[TBL] [Abstract][Full Text] [Related]
27. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
Hayashi Y; Katada J; Sato Y; Igarashi K; Takiguchi Y; Harada T; Muramatsu M; Yasuda E; Uno I
Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
[TBL] [Abstract][Full Text] [Related]
28. Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.
Scarborough RM; Naughton MA; Teng W; Hung DT; Rose J; Vu TK; Wheaton VI; Turck CW; Coughlin SR
J Biol Chem; 1992 Jul; 267(19):13146-9. PubMed ID: 1320011
[TBL] [Abstract][Full Text] [Related]
29. Extracellular mutations of protease-activated receptor-1 result in differential activation by thrombin and thrombin receptor agonist peptide.
Blackhart BD; Ruslim-Litrus L; Lu CC; Alves VL; Teng W; Scarborough RM; Reynolds EE; Oksenberg D
Mol Pharmacol; 2000 Dec; 58(6):1178-87. PubMed ID: 11093752
[TBL] [Abstract][Full Text] [Related]
30. Interaction mode of the phe-phenyl group of thrombin receptor-tethered ligand SFLLRNP in receptor activation.
Nose T; Fujita T; Nakajima M; Inoue Y; Costa T; Shimohigashi Y
J Biochem; 1998 Aug; 124(2):354-8. PubMed ID: 9685726
[TBL] [Abstract][Full Text] [Related]
31. Conformational analysis of the thrombin receptor agonist peptides SFLLR and SFLLR-NH2 by NMR: evidence for a cyclic bioactive conformation.
Matsoukas J; Hollenberg MD; Mavromoustakos T; Panagiotopoulos D; Alexopoulos K; Yamdagni R; Wu Q; Moore GJ
J Protein Chem; 1997 Feb; 16(2):113-31. PubMed ID: 9112605
[TBL] [Abstract][Full Text] [Related]
32. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
33. In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist.
Kato Y; Kita Y; Nishio M; Hirasawa Y; Ito K; Yamanaka T; Motoyama Y; Seki J
Eur J Pharmacol; 1999 Nov; 384(2-3):197-202. PubMed ID: 10611442
[TBL] [Abstract][Full Text] [Related]
34. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes.
Hollenberg MD; Laniyonu AA; Saifeddine M; Moore GJ
Mol Pharmacol; 1993 Jun; 43(6):921-30. PubMed ID: 8391118
[TBL] [Abstract][Full Text] [Related]
35. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function.
Lerner DJ; Chen M; Tram T; Coughlin SR
J Biol Chem; 1996 Jun; 271(24):13943-7. PubMed ID: 8662993
[TBL] [Abstract][Full Text] [Related]
36. Edge-to-face CH/pi interaction between ligand Phe-phenyl and receptor aromatic group in the thrombin receptor activation.
Matsushima A; Fujita T; Nose T; Shimohigashi Y
J Biochem; 2000 Aug; 128(2):225-32. PubMed ID: 10920258
[TBL] [Abstract][Full Text] [Related]
37. Structure around the cleavage site in the thrombin receptor determined by NMR spectroscopy.
Smith KJ; Trayer IP; Grand RJ
Biochemistry; 1994 May; 33(20):6063-73. PubMed ID: 8193120
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
Girnys EA; Sobczyk-Kojiro K; Mosberg HI
Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
[TBL] [Abstract][Full Text] [Related]
40. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
